Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Berenberg raises target price on Warpaint London

(Sharecast News) - Analysts at Berenberg slightly raised their target price on cosmetics firm Warpaint London from 680.0p to 700.0p on Monday, noting the group's margin management was not to be overlooked. Berenberg said Warpaint's minor revenue miss reported in its FY24 trading update did not detract from its conviction in the sustainability of the group's growth opportunity.

"We see the -28% share price reaction since the announcement as an overreaction given our perception of the cyclicality of the slowdown," said Berenberg, which has a 'buy' rating on the stock.

The German bank also noted that Warpaint reported revenues that were 4% below consensus in FY24, yet crucially, it stated this was followed by "a sharp reacceleration in growth" through January, to 15% year-on-year.

"While the weakness in December is disappointing, we continue to see a significant runway of revenue growth ahead, primarily due to the yet-to-be-won component of the existing customer store estate, which Warpaint is pursuing expansion within," concluded Berenberg.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Ibstock earnings dip as expected in 'progressively tougher market'
(Sharecast News) - Building products manufacturer Ibstock reported a drop in full-year earnings on Thursday, in line with revised guidance, in a "progressively tougher market".
OSB hikes dividend, launches buyback after fall in profit
(Sharecast News) - OSB Group reported a decline in annual profit for 2025 on Thursday as higher administrative costs and an impairment charge weighed on earnings, though the specialist lender said loan growth and originations increased and it announced a £100m share buyback alongside a higher dividend.
Spire Healthcare grows annual profits, but NHS outlook uncertain in 2026
(Sharecast News) - Takeover target and Spire Healthcare reported a small rise in adjusted profits over 2025 which it hailed as a "resilient performance" against a backdrop of significant cost headwinds, though the outlook for 2026 was proving more uncertain due to a drop in NHS commissioning activity.
Bloomsbury shares spark on 2027 profit outlook
(Sharecast News) - Shares in Bloomsbury Publishing shot higher on Thursday after it said profit for the year ending 28 February 2027 was set to be "materially ahead" of market expectations as Sarah J. Maas will publish her next two novels within the next year.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.